SCHEMBL22271053

SCHEMBL22271053

CNc1ccc(-c2nccnc2NCc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ HIF1A Q16665 3/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ KDR P35968 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ FABP1 P07148 1/20 0.41
▸ FABP6 P51161 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ PSMB1 P20618 1/20 0.40
▸ UTS2R Q9UKP6 1/20 0.40
▸ FLT1 P17948 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18448734 0.82 MAPK1 (0.48) HPGDNPSR1HIF1AALDH1A1KMT2A
SCHEMBL28238899 0.73 FYN (0.51) HPGDNPSR1HIF1AALDH1A1KMT2A
SCHEMBL22270578 0.73 ALDH1A1 (0.47) HPGDALDH1A1KMT2AHTTMEN1
SCHEMBL22270647 0.72 CSF1R (0.41) HIF1AALDH1A1HTTKDM4EMAPK1
SCHEMBL19091942 0.72 FFAR1 (0.63) HIF1AKMT2AHTTMEN1CYP1A2
N-Benzylaniline SCHEMBL7330342 0.70 HTT (0.64) ALDH1A1KMT2AHTTKDM4EMEN1
SCHEMBL24124718 0.69 HTT (0.62) HIF1AKMT2AHTTMEN1CYP1A2
SCHEMBL18448955 0.69 HIF1A (0.47) HIF1AKMT2AHTTKDM4EMEN1
SCHEMBL2785512 0.68 ALDH1A1 (0.50) HPGDNPSR1ALDH1A1KMT2AHTT
SCHEMBL22620565 0.68 FFAR1 (0.54) HIF1AKMT2AHTTMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback